CLB Core Laboratories N V

  1. Stocks
  2. Energy
  3. NYSE: CLB

Price (delayed)

$11.46

Market cap

$528.27M

P/E Ratio

18.19

Dividend/share

$0.04

EPS

$0.63

Enterprise value

$673.29M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 51

Core Laboratories N.V. is a leading provider of proprietary and patented reservoir description and production enhancement services and products used to optimize petroleum reservoir performance. The Company has over 70 ...

Highlights
The stock's price to earnings (P/E) is 55% less than its 5-year quarterly average of 40.5 and 16% less than its last 4 quarters average of 21.7
CLB's equity is up by 6% YoY
CLB's debt is down by 7% YoY but it is up by 2.3% from the previous quarter
CLB's gross profit is down by 4% since the previous quarter but it is up by 2.1% year-on-year
The quick ratio has decreased by 7% YoY and by 3.1% QoQ
The gross margin has decreased by 3.9% QoQ
Sector: Energy
Industry: Oil & Gas Equipment & Services
Website: http://www.corelab.com
Peers: OII SLB FISV HAL

Key stats

What are the main financial stats of CLB

CLB stock price

How has the Core Laboratories N V stock price performed over time
Intraday
-0.95%
1 week
4.95%
1 month
-15.74%
1 year
-11.16%
YTD
-28.51%
QTD
-1.63%

Financial performance

How have Core Laboratories N V's revenue and profit performed over time
Revenue
$524.73M
Gross profit
$104.54M
Operating income
$53.94M
Net income
$29.03M
Gross margin
19.9%
Net margin
5.5%
CLB's gross profit is down by 4% since the previous quarter but it is up by 2.1% year-on-year
The operating margin has decreased by 3.7% from the previous quarter
Core Laboratories N V's operating income has decreased by 4.5% QoQ
CLB's net income is up by 3.6% year-on-year but it is down by 2.1% since the previous quarter

Price vs fundamentals

How does CLB's price correlate with its fundamentals

Growth

What is Core Laboratories N V's growth rate over time

Valuation

What is Core Laboratories N V stock price valuation
CLB P/E details
P/E
18.19
P/B
1.96
P/S
1.01
EV/EBIT
12.61
EV/EBITDA
9.89
EV/Sales
1.28
The stock's price to earnings (P/E) is 55% less than its 5-year quarterly average of 40.5 and 16% less than its last 4 quarters average of 21.7
Core Laboratories N V's EPS has decreased by 3.1% from the previous quarter
The P/B is 55% below the 5-year quarterly average of 4.4 and 22% below the last 4 quarters average of 2.5
CLB's equity is up by 6% YoY
CLB's price to sales (P/S) is 44% lower than its 5-year quarterly average of 1.8 and 22% lower than its last 4 quarters average of 1.3

Efficiency

How efficient is Core Laboratories N V business performance
The return on invested capital is up by 6% year-on-year but it has declined by 2.9% since the previous quarter
The return on equity has declined by 3.5% since the previous quarter and by 3.5% year-on-year
The ROA has grown by 4.3% YoY but it has contracted by 2% from the previous quarter
Core Laboratories N V's ROS has decreased by 3.8% from the previous quarter

Dividends

What is CLB's dividend history
Dividend details
DPS
$0.04
Dividend yield
0.35%
Payout ratio
6.3%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Core Laboratories N V financials performed over time
The total assets is 88% greater than the total liabilities
The quick ratio has decreased by 7% YoY and by 3.1% QoQ
CLB's current ratio is down by 7% year-on-year
CLB's debt is 38% less than its equity
The debt to equity has decreased by 13% YoY
CLB's debt is down by 7% YoY but it is up by 2.3% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.